These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 10655300)

  • 1. Successful treatment of recurrent pelvic desmoid tumour with tamoxifen: case report.
    Chao AS; Lai CH; Hsueh S; Chen CS; Yang YC; Soong YK
    Hum Reprod; 2000 Feb; 15(2):311-3. PubMed ID: 10655300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A recurrent pelvic desmoid tumor successfully treated with tamoxifen.
    Sportiello DJ; Hoogerland DL
    Cancer; 1991 Mar; 67(5):1443-6. PubMed ID: 1991311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tamoxifen for recurrent desmoid tumor of the chest wall.
    Ohashi T; Shigematsu N; Kameyama K; Kubo A
    Int J Clin Oncol; 2006 Apr; 11(2):150-2. PubMed ID: 16622751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-dose tamoxifen and sulindac as first-line treatment for desmoid tumors.
    Hansmann A; Adolph C; Vogel T; Unger A; Moeslein G
    Cancer; 2004 Feb; 100(3):612-20. PubMed ID: 14745880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiotherapy and tamoxifen for aggressive fibromatosis--a case report.
    Vidayasagar MS; Rao NR; Sudha VS; Fernandes DJ
    J Assoc Physicians India; 1996 Jan; 44(1):58-60. PubMed ID: 8773099
    [No Abstract]   [Full Text] [Related]  

  • 6. Fatal Outcome of Recurrent Infantile Pelvic Desmoid Tumor Treated with Tamoxifene.
    Amaadour L; Benbrahim Z; Zouiten O; Bourdi N; Alaoui YL; El Mazti A; Hammas N; Mellas N
    Gulf J Oncolog; 2018 Jan; 1(26):75-78. PubMed ID: 29607829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surgical excision versus observation as initial management of desmoid tumors: A population based study.
    Turner B; Alghamdi M; Henning JW; Kurien E; Morris D; Bouchard-Fortier A; Schiller D; Puloski S; Monument M; Itani D; Mack LA
    Eur J Surg Oncol; 2019 Apr; 45(4):699-703. PubMed ID: 30420189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modification of growth of desmoid tumours in tissue culture by anti-oestrogenic substances: a preliminary report.
    Serpell JW; Paddle-Ledinek JE; Johnson WR
    Aust N Z J Surg; 1996 Jul; 66(7):457-63. PubMed ID: 8678875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regression of large pelvic desmoid tumor by tamoxifen and sulindac.
    Izes JK; Zinman LN; Larsen CR
    Urology; 1996 May; 47(5):756-9. PubMed ID: 8650880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pelvic fibromatosis (desmoid)--treatment with steroids and tamoxifen.
    Mukherjee A; Malcolm A; de la Hunt M; Neal DE
    Br J Urol; 1995 Apr; 75(4):559-60. PubMed ID: 7788276
    [No Abstract]   [Full Text] [Related]  

  • 11. Stabilization and regression of a recurrent desmoid tumor with the antiestrogen toremifene.
    Maseelall P; Robins JC; Williams DB; Thomas MA
    Fertil Steril; 2005 Aug; 84(2):509. PubMed ID: 16086575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Noncytotoxic drug therapy in children with unresectable desmoid tumors.
    Lackner H; Urban C; Kerbl R; Schwinger W; Beham A
    Cancer; 1997 Jul; 80(2):334-40. PubMed ID: 9217047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of mesenteric desmoid tumours with the anti-oestrogenic agent toremifene: case histories and an overview of the literature.
    Bus PJ; Verspaget HW; van Krieken JH; de Roos A; Keizer HJ; Bemelman WA; Vasen HF; Lamers CB; Griffioen G
    Eur J Gastroenterol Hepatol; 1999 Oct; 11(10):1179-83. PubMed ID: 10524651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation between tumor growth and hormonal therapy with MR signal characteristics of desmoid-type fibromatosis: A preliminary study.
    Gondim Teixeira PA; Chanson A; Verhaeghe JL; Lecocq S; Louis M; Hossu G; Blum A
    Diagn Interv Imaging; 2019 Jan; 100(1):47-55. PubMed ID: 30037746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Desmoid tumor sensitive to tamoxifen].
    Maroy B
    Presse Med; 1997 Oct; 26(32):1520-2. PubMed ID: 9435830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TAMOXIFEN RETINOPATHY DURING TREATMENT OF AN INOPERABLE DESMOID TUMOR.
    Furst M; Somogyi MB; Wong RW; Araujo D; Harper CA
    Retin Cases Brief Rep; 2020; 14(3):268-270. PubMed ID: 29227350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breast fibromatosis response to tamoxifen: dynamic MRI findings and review of the current treatment options.
    Plaza MJ; Yepes M
    J Radiol Case Rep; 2012 Mar; 6(3):16-23. PubMed ID: 22690287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term follow-up of a recurrent multifocal desmoid tumour treated with tamoxifen: a case report.
    Gwynne-Jones DP; Theis JC; Jeffery AK; Hung NA
    J Orthop Surg (Hong Kong); 2005 Aug; 13(2):174-7. PubMed ID: 16131682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of recurrent desmoid tumour with tamoxifen.
    Thomas S; Datta-Gupta S; Kapur BM
    Aust N Z J Surg; 1990 Nov; 60(11):919-21. PubMed ID: 2241656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mesenteric fibromatosis: a report of three cases and literature review.
    Kabra V; Chaturvedi P; Pathak KA; deSouza LJ
    Indian J Cancer; 2001; 38(2-4):133-6. PubMed ID: 12593452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.